Australia markets closed

Fulgent Genetics, Inc. (FLGT)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
38.74+0.65 (+1.71%)
As of 09:56AM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
925,148
992,584
421,712
32,528
21,351
Cost of revenue
243,390
215,533
89,807
14,107
10,697
Gross profit
681,758
777,051
331,905
18,421
10,654
Operating expenses
Research development
26,379
24,219
11,580
6,537
5,534
Selling general and administrative
123,434
75,171
30,167
12,312
10,190
Total operating expenses
154,002
101,098
41,747
18,849
15,724
Operating income or loss
527,756
675,953
290,158
-428
-5,070
Income before tax
526,324
677,300
291,684
409
-4,636
Income tax expense
135,767
174,795
72,532
43
36
Income from continuing operations
390,557
506,239
214,310
-411
-5,607
Net income
392,377
507,364
214,310
-411
-5,607
Net income available to common shareholders
392,377
507,364
214,310
-411
-5,607
Basic EPS
-
17.25
9.44
-0.02
-0.25
Diluted EPS
-
16.38
8.91
-0.02
-0.25
Basic average shares
-
29,408
22,694
18,709
17,978
Diluted average shares
-
30,976
24,056
18,709
17,978
EBITDA
-
686,957
293,120
1,679
-2,907